ANCARADNCT01937780
Anal Cancer Radiotherapy Study
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 8 versions: 6 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 5 words
- Study completion pushed from Dec 2025 to May 2027
- Secondary endpoints: details revised at 1 of 4 entries
- Publications: details revised at 1 of 1 entry
- Minor Study completion date: Dec 2024 to Dec 2025v7
- Minor Study completion date: Jan 2024 to Dec 2024v6
- Notable Primary completion date: Sep 2021 to Sep 2022v4
- Notable Start date: Aug 2013 to Oct 4, 2013
- Trial status: Recruiting to Active, Not Recruiting
- Study completion date: Jan 2024
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Disease-free survival
Timeframe: 3 years
Secondary (4)
Prediction of local recurrence
Biomarker ability to predict local recurrence rate
Improvement of faecal incontinence
Pain relief of palliative radiotherapy
Sites
1 site in 1 country
- Oslo University HospitalOslo, Norway